BNP Paribas Financial Markets’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $93.7M | Buy |
1,698,298
+1,321,421
| +351% | +$71.6M | 0.06% | 436 |
|
|
2025
Q4 | $18.5M | Buy |
376,877
+330,906
| +720% | +$15.4M | 0.01% | 1232 |
|
|
2025
Q3 | $1.98M | Buy |
45,971
+34,572
| +303% | +$1.35M | ﹤0.01% | 2619 |
|
|
2025
Q2 | $438K | Sell |
11,399
-8,630
| -43% | -$330K | ﹤0.01% | 3405 |
|
|
2025
Q1 | $776K | Sell |
20,029
-347,286
| -95% | -$12.7M | ﹤0.01% | 2946 |
|
|
2024
Q4 | $12.4M | Buy |
+367,315
| New | +$13.2M | 0.01% | 1240 |
|
|
2022
Q3 | – | Sell |
-3,218,302
| Closed | -$175M | – | 4850 |
|
|
2022
Q2 | $175M | Buy |
3,218,302
+21,472
| +0.7% | +$1.19M | 0.4% | 79 |
|
|
2022
Q1 | $174M | Buy |
3,196,830
+100,708
| +3% | +$5.47M | 0.35% | 79 |
|
|
2021
Q4 | $171M | Sell |
3,096,122
-1,707,949
| -36% | -$88.8M | 0.41% | 77 |
|
|
2021
Q3 | $229M | Sell |
4,804,071
-4,913
| -0.1% | -$247K | 0.54% | 58 |
|
|
2021
Q2 | $239M | Buy |
4,808,984
+4,798,605
| +46,234% | +$231M | 0.46% | 61 |
|
|
2021
Q1 | $463K | Sell |
10,379
-27,836
| -73% | -$1.26M | ﹤0.01% | 2605 |
|
|
2020
Q4 | $1.76M | Buy |
38,215
+30,820
| +417% | +$1.42M | 0.01% | 1683 |
|
|
2020
Q3 | $348K | Sell |
7,395
-339
| -4% | -$17K | ﹤0.01% | 2430 |
|
|
2020
Q2 | $394K | Buy |
7,734
+1,872
| +32% | +$96K | ﹤0.01% | 2198 |
|
|
2020
Q1 | $278K | Sell |
5,862
-24,694
| -81% | -$1.32M | ﹤0.01% | 2685 |
|
|
2019
Q4 | $1.79M | Sell |
30,556
-37,211
| -55% | -$2.07M | 0.01% | 1730 |
|
|
2019
Q3 | $3.62M | Buy |
67,767
+10,593
| +19% | +$545K | 0.01% | 1224 |
|
|
2019
Q2 | $2.86M | Sell |
57,174
-2,943
| -5% | -$148K | 0.01% | 1298 |
|
|
2019
Q1 | $3.14M | Buy |
60,117
+35,750
| +147% | +$1.79M | 0.01% | 1195 |
|
|
2018
Q4 | $1.16M | Sell |
24,367
-14,109
| -37% | -$695K | 0.01% | 1535 |
|
|
2018
Q3 | $1.93M | Buy |
38,476
+2,505
| +7% | +$127K | ﹤0.01% | 1508 |
|
|
2018
Q2 | $1.81M | Sell |
35,971
-6,943
| -16% | -$350K | 0.01% | 1517 |
|
|
2018
Q1 | $2.1M | Sell |
42,914
-8,384
| -16% | -$390K | 0.01% | 1368 |
|
|
2017
Q4 | $2.27M | Sell |
51,298
-30,567
| -37% | -$1.41M | 0.01% | 1416 |
|
|
2017
Q3 | $4.15M | Sell |
81,865
-3,041
| -4% | -$154K | 0.01% | 857 |
|
|
2017
Q2 | $4.58M | Sell |
84,906
-6,637
| -7% | -$354K | 0.01% | 806 |
|
|
2017
Q1 | $4.82M | Buy |
91,543
+14,105
| +18% | +$716K | 0.01% | 780 |
|
|
2016
Q4 | $3.73M | Sell |
77,438
-47,844
| -38% | -$2.36M | 0.02% | 671 |
|
|
2016
Q3 | $6.75M | Buy |
125,282
+11,495
| +10% | +$630K | 0.03% | 377 |
|
|
2016
Q2 | $6.16M | Buy |
113,787
+2,457
| +2% | +$129K | 0.03% | 414 |
|
|
2016
Q1 | $5.64M | Buy |
111,330
+22,620
| +25% | +$1.13M | 0.02% | 524 |
|
|
2015
Q4 | $4.47M | Buy |
88,710
+11,107
| +14% | +$566K | 0.01% | 661 |
|
|
2015
Q3 | $3.73M | Sell |
77,603
-66,022
| -46% | -$3.44M | 0.01% | 713 |
|
|
2015
Q2 | $7.48M | Buy |
143,625
+97,190
| +209% | +$5.47M | 0.02% | 462 |
|
|
2015
Q1 | $2.68M | Sell |
46,435
-34,670
| -43% | -$1.99M | 0.01% | 787 |
|
|
2014
Q4 | $4.33M | Buy |
81,105
+379
| +0.5% | +$21.2K | 0.02% | 698 |
|
|
2014
Q3 | $4.64M | Buy |
80,726
+71,314
| +758% | +$4.37M | ﹤0.01% | 750 |
|
|
2014
Q2 | $608K | Sell |
9,412
-191
| -2% | -$12.9K | ﹤0.01% | 1410 |
|
|
2014
Q1 | $665K | Buy |
9,603
+5,345
| +126% | +$361K | ﹤0.01% | 1325 |
|
|
2013
Q4 | $284K | Sell |
4,258
-414,650
| -99% | -$26.9M | ﹤0.01% | 1430 |
|
|
2013
Q3 | $26.3M | Buy |
418,908
+413,632
| +7,840% | +$26.6M | 0.02% | 276 |
|
|
2013
Q2 | $330K | Buy |
+5,276
| New | +$335K | ﹤0.01% | 1917 |
|
Other funds holding GSK
JEST
